PRoduct Iinkcukacha:
Imbonakalo | umgubo omhlophe |
Ukubonakala kwesisombululo | Isisombululo esicacileyo, esingenambala kwi-1N HCL (50mg/ml) |
Isazisi(TLC) | iyathobela |
Ubunyulu(TLC) | ≧99.0% |
Umxholo we-Enantiomer(HPLC)L-enantiomer | ≦0.5% |
Uvavanyo (EA, njengoko injalo) | ≧96.0% |
Ixesha lokuqinisekisa | iminyaka eyi-2 |
Iphakheji | 25kg / igubu |
Ugcino | Gcina kwindawo emnyama, itywinwe kwindawo eyomileyo, ubushushu beGumbi |
Ezothutho | ngolwandle okanye ngomoya okanye emhlabeni |
Ilizwe lemveli | eTshayina |
Immimiselo yokuhlawula | T/T |
Izithethantonye:
(R) -2-Amino-4-methylpentanoic acid;
D-2-Amino-4-methylpentanoicacid;
(2R) -2-amino-4-methylpentanoic acid;
D-Homo-valine;
I-D-2-Amino-4-methylvaleric acid;
Isicelo:
D-Leucinei-isomer engeyiyo yendalo ye-L-Leucine esebenza njenge-auto-inhibitor ye-lactic streptococci kwinkcubeko. I-D-Leucine ibangela i-analgesia ebantwini kwaye ikwabonisa umsebenzi wokuthintela kwiinkcubeko zeeseli zebhaktheriya.
I-D-leucine inomsebenzi we-antiepileptic, ephezulu kunaleyo ye-L-leucine. I-D-leucine inokuphelisa ngokufanelekileyo ukuxhuzula. Kwi-vitro, i-D-leucine inokunciphisa indawo yexesha elide, kodwa ayinayo impembelelo kwi-basal synaptic transmission.
Kuphando lwe-biochemical.
Ukongama:
1. Ngokuqhelekileyo sinezinga letoni kwisitokhwe, kwaye sinokuhambisa izinto ngokukhawuleza emva kokufumana umyalelo.
2. Umgangatho ophezulu kunye nexabiso elikhuphisanayo linokubonelelwa.
3. Ingxelo yohlalutyo lomgangatho (COA) yebhetshi yokuthunyelwa iya kubonelelwa phambi kokuthunyelwa.
4. Ikhweshine yomthengisi kunye namaxwebhu obugcisa anokubonelelwa ukuba kucelwe emva kokudibana nesixa esithile.
5. Inkonzo enkulu emva kokuthengisa okanye isiqinisekiso : Nawuphi na umbuzo wakho ungasonjululwa ngokukhawuleza.